drugset / Trial / NCT02766777
Evaluation of the Safety of Lubiprostone in Pediatric Participants Aged ≥ 6 Years to < 18 Years With Functional Constipation
NaSingle-groupOpen-labelTreatment
Summary
A study of the safety of lubiprostone in pediatric participants aged ≥ 6 Years to \< 18 years diagnosed with functional constipation.
Timeline
- Start
- 2016-04-12
- Primary completion
- 2016-11-04
- Completion
- 2016-11-04
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Lubiprostone | Small molecule | 12 ug | Oral |
| Subject | Lubiprostone | Small molecule | 24 ug | Oral |